Twitter   Facebook   e-Newsletters   Podcsts   RSS Feeds   Share

74
International Pharmaceutical Abstracts
ONTAP® International Pharmaceutical Abstracts (File 274)

Last Loaded on Web: Tuesday, October 01, 2013

Last Update To Bluesheet: September 6, 2013

Bluesheet Contents     PDF version

File Description Print Counterparts Special Features Sample Record Sort Rates
Subject Coverage Dialog File Data DIALINDEX/OneSearch Categories Basic Index Rank
Sources Document Types Indexed Contact Additional Indexes Map
Tips Geographic Coverage Terms and Conditions Limit Predefined Format Options


File Description [top]

International Pharmaceutical Abstracts (IPA) provides information on all phases of the development and use of drugs and on professional pharmaceutical practice. In early 1985 coverage was expanded to include state pharmacy journals that deal with state regulations, salaries, guidelines, manpower studies, laws, and more. The scope of the database ranges from the clinical, practical, and theoretical to the economic and scientific aspects of the literature. A unique feature of abstracts reporting clinical studies is the inclusion of the study design, number of patients, dosage, dosage forms, and dosage schedule. IPA is essential to anyone interested in keeping abreast of today's health related drug literature. ONTAP® International Pharmaceutical Abstracts, File 274, is available for ONline Training and Practice.



Tips [top]

USE FILE 74

to follow all phases of drug development and track the pharmaceutical industry in general.

USE /NA OR NA=

to search for specific chemical names:

     SELECT ACETAMINOPHEN/NA

USE RN=

to search by CAS(R) Registry Number:

     SELECT RN=103-90-2

USE /SH OR SH=

to search for Section Headings:

     SELECT SH=PHARMACEUTICAL TECHNOLOGY


Subject Coverage [top]

  • Adverse Drug Reactions
  • Biopharmaceutics
  • Drug Analysis
  • Drug Evaluations
  • Drug Interactions
  • Drug Metabolism and Body Distribution
  • Drug Stability
  • History
  • Information Processing and Literature
  • Institutional Pharmacy Practice
  • Investigational Drugs
  • Legislation, Laws, and Regulations
  • Methodology and Drug Testing
  • Pharmaceutical Chemistry
  • Pharmaceutical Technology
  • Pharmaceutics
  • Pharmacoeconomics
  • Pharmacognosy
  • Pharmacy Practice
  • Pharmacology
  • Sociology, Economics, and Ethics
  • Toxicity


Sources [top]

International Pharmaceutical Abstracts draws material from over 850 primary journals from throughout the world and from all U.S. state pharmacy journals.



Print Counterparts [top]

  • International Pharmaceutical Abstracts


Dialog File Data [top]

Dates Covered: 1970 to the present
File Size: More than 381,900 records as of April 2004 (File 74)
14,431 records as of December 1997 (File 274)
Update Frequency: Biweekly (Approximately 500 records per update) (File 74)
Closed (File 274)


Document Types Indexed [top]

  • Journal Articles


Geographic Coverage [top]

  • International


Geographic Restrictions [top]

  • None


Special Features [top]

  • ERA Available
  • Graduate Education Program
  • KWIC and HILIGHT Available
  • DIALOG Alert Available
  • Remove Duplicates (RD, ID) Available
  • CURRENT Feature Available
  • eLinks Enabled Database
  • Online Thesaurus corresponding to IPA Thesaurus of Subject Terms
  • MAP Available


DialIndex/OneSearch Categories [top]

ACRONYM CATEGORY NAME
CASREGNO CAS(R) Registry Numbers-Chemical and Medical Files
DRUGECON Pharmacoeconomics
MEDDEV Medical Devices
MEDENG Medical Engineering
PHARM Pharmacology
PHARMR Pharmacology + RINGDOC-Files
REGS Regulations
RNMED CAS(R) Registry Numbers - Medical Files
SAFETY Safety
TOXICOL Toxicology


Contact [top]

International Pharmaceutical Abstracts is provided by Thomson Reuters (Scientific). Questions concerning file content should be directed to:


Thomson Reuters (Scientific)
Customer Support Desk
1500 Spring Garden Street
4th Floor
Philadelphia, PA 19130
U.S.
Telephone: +1-215-386-0100 (worldwide)
800 Line: +1-800-336-4474 (U.S., Canada)
Fax: +1-215-386-6362
E-Mail: http://scientific.thomsonreuters.com/support/techsupport


Terms and Conditions [top]

ONTAP is a registered trademark of Dialog LLC

For Dialog's Redistribution and Archive Policy, enter HELP ERA online. The following terms and conditions also apply.

International Pharmaceutical Abstracts (File 74)

This data is copyrighted by The Thomson Corp. The Thomson Corp. represents that the database provided hereunder was formulated with a reasonable standard of care, and in conformance to professional standards in the field. Except with respect to the foregoing and as otherwise specifically provided in this agreement, The Thomson Corp. makes no representations or warranties, express or implied, including but not limited to, any implied warranty of merchantability or fitness for a particular purpose, with respect to such database and specifically disclaims all such warranties and representations.


Dialog Standard Terms & Conditions apply.


SAMPLE RECORD [top]

    DIALOG(R)File  74:Int.Pharm.Abs 
    (c) 2004 The Thomson Corporation. All rts. reserv. 
     
  AA=  00076774  20-00205 
  /TI  STUDY ON THE DISSOLUTION AND BIOAVAILABILITY OF DIRECTLY COMPRESSED 
    SALICYLAMIDE TABLETS 
  AU=  Sakr, A. M.; Aboutaleb, A. E.; Kassem, A. A.; Khidr, S. H. 
  CS=  Dept. of Industrial Pharm., Assiut Univ., Assiut, Egypt 
  JN=,PY=  Pharmazeutische Industrie (Germany), V42, (4), p412-415, 1980 
  CD=,SN=,LA=,SL=  CODEN: PHINAN  ISSN: 0031-711X  LANGUAGE: English  SUMMARY LANGUAGE: German 
  RT=  RECORD TYPE: Abstract 
     
  /AB       Salicylamide (I) tablet formulations directly compressed with 
    microcrystalline cellulose (Avicel PH-101) or starch STA-Rx-1500) were 
    evaluated with regard to their dissolution behavior and their availability 
    in 6 subjects. 
         It was shown that the type and concentration of the excipients can 
    affect the disintegration time, dissolution rate, and availability. The 
    absorption of total I was dissolution rate limited. It was possible to 
    correlate the initial absorption and dissolution rates of the different 
    formulations with their availability. 
         Microcrystalline cellulose, at a concentration of 43%, proved to be 
    the best tableting excipient. (17 references) 
     
  RN=,/NA, NA=  CAS REGISTRY NUMBERS: 65-45-2 (Salicylamide); 9005-25-8 (Starch); 
       9004-34-6 (Cellulose microcrystalline) 
  /TN,TN=  CHEMICAL/BRAND NAMES:  Avicel PH-101 ; STA-Rx-1500 
  /DE  DESCRIPTORS: Concentration -- cellulose microcrystalline, compression, 
      direct, salicylamide tablets, effects, properties; Concentration -- 
      starch, compression, direct, salicylamide tablets, effects, properties; 
      Excipients -- cellulose microcrystalline, compression, direct, 
      salicylamide, availability, humans; Excipients -- starch, compression, 
      direct, salicylamide, availability, humans;  Analgesics  and 
      antipyretics  -- salicylamide, compression, direct, excipients, 
      dissolution, availability, humans; Absorption -- salicylamide, tablets, 
      direct compressed, relation, dissolution rates, humans; Dissolution rates 
      -- salicylamide, tablets, direct compressed, relation, availability, 
      humans; Disintegration -- salicylamide, tablets, direct compressed, 
      relation, availability, humans; Drugs, availability -- salicylamide, 
      tablets, direct compressed, relation, dissolution rates, humans 
  /SH,SH=,/PR  SECTION HEADINGS: Biopharmaceutics (08); Pharmaceutics (09) 
  /TC,TC=,AH=  THERAPEUTIC CLASS: 28.08 (Analgesics and antipyretics) 
     


BASIC INDEX [top]

SEARCH
SUFFIX
DISPLAY
CODE
FIELD NAME
INDEXING
SELECT EXAMPLES
None None All Basic Index Fields Word S MICROCRYSTALLINE(W)CELLULOSE
/AB AB Abstract1 Word S REPROCESSING(W)METHOD/AB
/DE DE Descriptor2 Word
& Phrase
S ANALGESICS(1W)ANTIPYRETICS/DE
S "ANALGESICS AND ANTIPYRETICS"/DE
/NA NA Chemical Name3,4 Word
& Phrase
S CELLULOSE(W)MICROCRYSTALLINE/NA
S CELLULOSE MICROCRYSTALLINE/NA
/PR PR Primary Section Heading4 Word S PHARMACEUTICAL(W)TECHNOLOGY/PR
/SH SH Section Heading Name4 Word S PHARMACEUTICAL TECHNOLOGY/SH
/TC TC Therapeutic Class Name Word S ANALGESICS(1W)ANTIPYRETICS/TC
/TI TI Title Word S MICROCRYSTALLINE(W)CELLULOSE/TI
/TN TN Brand Name4 Word
& Phrase
S AVICEL(W)PH/TN
S AVICEL PH-101/TN

1 All records include abstracts.

2 Also /DF.

3 Includes brand, chemical, and drug names and laboratory codes.

4 Searchable in the Basic Index and in the Additional Indexes.


ADDITIONAL INDEXES [top]

SEARCH
PREFIX
DISPLAY
CODE
FIELD NAME
INDEXING
SELECT EXAMPLES
AA= AA IPA Accession Number Phrase S AA=10-64024
AH= AH AHFS Number, Therapeutic Class Code8 Phrase AH=28.08.08
None AN DIALOG Accession Number
AU= AU Author Phrase S AU=REILLY, W.J.
CD= CD CODEN Phrase S CO=DDIPD8
CS= CS Corporate Source Word S CS=(DEPT(1W)PHARMACEUTICS)
DT= DT Document Type Word S DT=LETTERS
JN= JN Journal Name Phrase S JN=DRUG DEVELOPMENT?
LA= LA Language Phrase S LA=ENGLISH
NA= NA Chemical Name3,4 Phrase S NA=CELLULOSE MICROCRYSTALLINE
PY= PY Publication Year Phrase S PY=1994
RN= RN CAS(R) Registry Number Phrase S RN=9004-34-6
RT= RT Record Type1 Phrase S RT=ABSTRACT
SH= PR Primary Section Heading4 Phrase S SH=PHARMACEUTICAL TECHNOLOGY
SH= SH Section Heading Code and Name4 Phrase S SH=09
S SH=PHARMACEUTICAL TECHNOLOGY
None SL Summary Language
SN= SN International Standard Serial Number (ISSN) Phrase S SN=0363-9045
None SO Source Information6
TC= TC Therapeutic Class Code5 Phrase TC=28.08
TN= TN Brand Name4 Phrase S TN=AVICEL PH-101
UD= None Update7 Phrase S UD=9999

5 Also searchable as AH=

6 Display includes journal name, volume, issue, pagination, and publication year.

7 Not available in file 274.

8 Also searchable as TC=


LIMIT [top]

SUFFIX FIELD NAME EXAMPLES
/ DIALOG Accession Number S S3/00100000-99999999
/ENG English-Language Articles S S2/ENG
/HUMAN Human Subject S S1/HUMAN
/NONENG Non-English-Language Articles S S4/NONENG
/YYYY Publication Year S S2/2000:2002


SORT [top]

SORTABLE FIELDS EXAMPLES
AU, JN, PY, TI SORT S1/ALL/PY/D
SORT S3/ALL/AU


RANK [top]

RANK FIELDS EXAMPLES
All phrase- and numeric-indexed fields in the Additional Indexes can be ranked. Other RANK codes include: DE RANK AU S3


MAP [top]

MAP FIELDS EXAMPLES
NA, RN MAP RN TEMP S2


USER-DEFINED FORMAT OPTIONS [top]

User-defined formats may be specified using the display codes indicated in the Search Options tables. TYPE S3/TI,NA,PY/1-5
PRINT S2/TI,AB/ALL


PREDEFINED FORMAT OPTIONS [top]

NO.
DIALOGWEB
FORMAT
RECORD CONTENT
1 -- DIALOG Accession Number
2 -- Bibliographic Citation and Indexing
3 Medium Bibliographic Citation
4 -- Full Record with Tagged Fields
5 -- Full Record
6 Short Title and Publication Year
7 Long Bibliographic Citation and Abstract
8 Free Title, Indexing, and Publication Year
9 Full Full Record
K -- KWIC (Key Word In Context) displays a window of text; may be used alone or with other formats


DIRECT RECORD ACCESS [top]

FIELD NAME EXAMPLES
DIALOG Accession Number TYPE 00234446/5
DISPLAY 00744483/9
PRINT 00224557/5


Rates [top]

Rates For File: International Pharmaceutical Abstracts[74]
Cost per DialUnit:                 $8.25
Cost per minute:                   $1.43
Report Elements                    $0.00
LOB Reports                        $0.00
SHARE Reports                      $0.00
CROSSTAB Report Records            $0.00
Rank Elements                      $0.00
ALERT (default)                    $6.75
ALERT (Monthly)                   $12.25
ALERT (Biweekly/twice a month)     $6.75
ALERT (Weekly)                 *   $5.00
ALERT (Daily)                  *   $5.00
ALERT (Calendar weekly)        *   $5.00
ALERT (Intraday)               *   $5.00
* = custom scheduled Alerts only
ALERT Number of included prints        0

Format    Types   Prints
     1    $0.00    $0.00
     2    $3.50    $3.50
     3    $3.50    $3.50
     4    $3.50    $3.50
     5    $3.50    $3.50
     6    $0.00    $0.00
     7    $3.50    $3.50
     8    $0.00    $0.00
     9    $3.25    $3.25
KWIC95    $0.31       NA
KWIC96    $0.31       NA

REDIST/COPY Multiplier Table:

      Range      Multiplier
        1-2       1.00
       3-25       1.50
     26-100       3.00
    101-200       4.00
    201-500       6.00
   501-1000       8.00
 1001 or more    10.00

ARCHIVE Multiplier Table:
      Range      Multiplier
       1-25       1.50
     26-200       3.00
    201-500       6.00
   501-1000       8.00
 1001 or more    10.00
Rates For File: ONTAP® International Pharmaceutical Abstracts[274]
Cost per DialUnit:                 $0.00
Cost per minute:                   $0.00
Rank Elements                      $0.00

Format    Types   Prints
     1    $0.00    $0.00
     2    $0.00    $0.00
     3    $0.00    $0.00
     4    $0.00    $0.00
     5    $0.00    $0.00
     6    $0.00    $0.00
     7    $0.00    $0.00
     8    $0.00    $0.00
     9    $0.00    $0.00
KWIC95    $0.00       NA
KWIC96    $0.00       NA

REDIST/COPY Multiplier Table:

      Range      Multiplier
        1-2       1.00
       3-25       1.50
     26-100       3.00
    101-200       4.00
    201-500       6.00
   501-1000       8.00
 1001 or more    10.00

ARCHIVE Multiplier Table:

      Range      Multiplier
       1-25       1.50
     26-200       3.00
    201-500       6.00
   501-1000       8.00
 1001 or more    10.00
[top]



All contents Copyright © Dialog, LLC. All rights reserved.
If you have any questions about, problems with, or corrections for our Web site,
please contact Customer Service for assistance.